Dificid (fidaxomicin)

pCPA File Number: 22141
Negotiation Status:
Concluded with an LOI
Indication(s):
Clostridium difficile infection
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: